Clinical Trials on Primary Hyperlipidemia or Mixed Dyslipidemia in New Zealand
Total 1107 results
-
Kowa Research Institute, Inc.CompletedMixed Dyslipidemia | Primary DyslipidemiaUnited States
-
AmgenCompletedHyperlipidemia and Mixed DyslipidemiaUnited States, Canada, Denmark, France, Italy, Belgium, Czechia, Taiwan, Japan, Switzerland, Germany, United Kingdom, Korea, Republic of, Hong Kong, Netherlands, New Zealand, South Africa, Australia, Spain, Austria, Hungary, Russian... and more
-
Orient Pharma Co., Ltd.CompletedPrimary Hypercholesterolemia | Mixed DyslipidemiasTaiwan, Australia, New Zealand
-
NeuroBo Pharmaceuticals Inc.CompletedSevere Hypertriglyceridemia | Mixed DyslipidaemiaUnited States, Canada
-
AmgenCompletedMixed Dyslipidemia | Primary HypercholesterolemiaUnited States, Canada
-
AmgenCompletedMixed Dyslipidemia | Primary HypercholesterolemiaUnited States, Canada
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyDaiichi Sankyo GermanyCompleted
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingHypercholesterolemia | Mixed DyslipidemiaAustria, United Kingdom, Italy, Germany, Belgium
-
Arisaph Pharmaceuticals IncUnknownHyperlipidemiaUnited States
-
PfizerTerminatedDyslipidemia | HyperlipidemiaUnited States
-
PfizerCompletedHyperlipidemiaUnited States, Spain, Taiwan, United Kingdom, Canada, Mexico, France, Hungary, Lithuania, Colombia, Romania, Russian Federation
-
PfizerCompletedDyslipidemia | Hypercholesterolemia | HyperlipidemiaUnited States
-
Kowa Research Institute, Inc.WithdrawnDyslipidemia | HyperlipidemiaUnited States
-
AstraZenecaCompletedHyperlipidaemiaDenmark, Netherlands, Spain, Czechia, United States, Slovakia, Hungary, Poland
-
PfizerTerminatedDyslipidemia | Hypercholesterolemia | HyperlipidemiaUnited States
-
Cortria CorporationMontreal Heart InstituteCompletedHypertriglyceridemia | Mixed HyperlipidemiaCanada
-
PfizerCompletedHyperlipidemiaFinland, Netherlands, United States, Canada, Sweden, Korea, Republic of, Singapore, Czechia, Poland, United Kingdom, Puerto Rico, Norway
-
Arrowhead PharmaceuticalsActive, not recruitingMixed DyslipidemiaUnited States, Australia, Canada, New Zealand
-
PfizerTIMI Study GroupCompletedDyslipidemias | Hyperlipidemias | HyperlipoproteinemiasUnited States, Canada, Poland
-
PfizerCompletedHyperlipidemiaKorea, Republic of, United States, Australia, Germany, Poland, Canada, Italy, Hong Kong, Czech Republic
-
Arrowhead PharmaceuticalsCompletedMixed DyslipidemiaUnited States, Australia, Poland, New Zealand, Canada, Hungary
-
Kowa Research Institute, Inc.WithdrawnDyslipidemia | HyperlipidemiaUnited States
-
PfizerTerminatedMixed HyperlipidemiaUnited States, Canada, Czech Republic, Finland, France, Netherlands
-
Arrowhead PharmaceuticalsCompletedDyslipidemias | Hypertriglyceridemia | Familial HypercholesterolemiaAustralia, New Zealand
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedHypertension | HyperlipidemiaGreece, Austria, Finland, Italy, Hungary, Belgium, Spain, Ireland, Portugal, Slovenia, Switzerland
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | Dyslipidemia | Hypercholesterolemia | Hypertriglyceridemia | HyperlipidemiaUnited States, Puerto Rico
-
Jamia Hamdard UniversityCompleted
-
AmgenCompletedType 2 Diabetes | Hypercholesterolemia | Mixed DyslipidemiaUnited States, Italy, Belgium, Spain, Canada, Poland, Mexico
-
Golden Biotechnology CorporationCompletedHyperlipidemiasTaiwan
-
Icahn School of Medicine at Mount SinaiActive, not recruitingPregnancy | HyperlipidemiaUnited States
-
AmgenCompletedHyperlipidemiaCanada, Denmark, France, United States, Czechia, New Zealand, Australia, South Africa, Italy, United Kingdom, Netherlands, Germany, Norway
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, Australia, Belgium, Canada
-
Cumberland PharmaceuticalsCompletedDyslipidemias | HypercholesterolemiaUnited States
-
Pharmena North AmericaCompletedHyperlipidemiaUnited States
-
Kowa Research EuropeCompletedDyslipidemia | Primary HypercholesterolemiaSpain, Denmark, India, Israel, Sweden, Finland, Germany, Italy, Netherlands, Norway, Poland, Russian Federation, United Kingdom
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, Belgium, Germany, Hong Kong, Netherlands, France, Australia, Canada, South Africa, United Kingdom, Spain, Poland, Switzerland
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States, Canada
-
ShionogiIntegriumCompletedCombined HyperlipidemiaUnited States
-
Yale UniversityWithdrawnHypertension | HyperlipidemiasUnited States
-
Esperion Therapeutics, Inc.CompletedHyperlipidemiaUnited States
-
Eli Lilly and CompanyTerminatedHyperlipidemiaUnited States, Puerto Rico
-
Bristol-Myers SquibbCompletedDyslipidemiaCanada, Australia, United States
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, Taiwan, Korea, Republic of, Australia, Belgium, Canada, South Africa, France, Turkey
-
PfizerCompletedHyperlipidemiaUnited States, Canada
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, Australia, Belgium, Spain, Finland, Sweden, Canada
-
NYU Langone HealthUniversity at Buffalo; New York City Health and Hospitals Corporation; Kowa Pharmaceuticals...CompletedHIV | HyperlipidemiaUnited States
-
AstraZenecaCompletedDyslipidemia, Hypercholesterolemia, HypertriglyceridemiaUnited States
-
Response PharmaceuticalsCompleted
-
AmgenTIMI Study GroupCompletedHyperlipidemiaUnited States, Canada, Denmark, Czechia, Hungary
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States, Canada